Chemoinformaics analysis of Isothymol isobutyrate
| Molecular Weight | 220.312 | nRot | 3 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 7 |
| Exact Molecular Weight | 220.146 | nRing | 1 |
| Solubility: LogS | -4.762 | nHRing | 0 |
| Solubility: LogP | 4.303 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 38.3199 |
| nHD | 0 | BPOL | 22.6681 |
| QED | 0.573 |
| Synth | 1.975 |
| Natural Product Likeliness | -0.189 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.391 |
| Pgp-sub | 0.005 |
| HIA | 0.057 |
| CACO-2 | -4.705 |
| MDCK | 0.0000237 |
| BBB | 0.952 |
| PPB | 0.937052 |
| VDSS | 0.706 |
| FU | 0.102404 |
| CYP1A2-inh | 0.882 |
| CYP1A2-sub | 0.906 |
| CYP2c19-inh | 0.826 |
| CYP2c19-sub | 0.917 |
| CYP2c9-inh | 0.698 |
| CYP2c9-sub | 0.794 |
| CYP2d6-inh | 0.253 |
| CYP2d6-sub | 0.665 |
| CYP3a4-inh | 0.319 |
| CYP3a4-sub | 0.544 |
| CL | 5.023 |
| T12 | 0.285 |
| hERG | 0.009 |
| Ames | 0.017 |
| ROA | 0.16 |
| SkinSen | 0.217 |
| Carcinogencity | 0.365 |
| EI | 0.883 |
| Respiratory | 0.265 |
| NR-Aromatase | 0.006 |
| Antiviral | Yes |
| Prediction | 0.76791 |